Synonyms: LY 2127399 | LY2127399
Compound class:
Antibody
Comment: Tabalumab is a monoclonal antibody directed against B-cell activating factor (BAFF, TNFSF13B). It was being developed as a treatment for autoimmune diseases [1] and B cell malignancies [2].
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. Peptide sequence BLAST search using the heavy chain variable region of tabalumab provides 100% match to a sequence claimed in patent US7317089 [3], and to the antibody with designation 4A5-3.1.1-B4. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9430 | tabalumab |
Synonyms ![]() |
LY 2127399 | LY2127399 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 385 |
Other databases | |
GtoPdb PubChem SID | 249565680 |
Search PubMed clinical trials | tabalumab |
Search PubMed titles | tabalumab |
Search PubMed titles/abstracts | tabalumab |
Wikipedia | Tabalumab |